Prashant J. Khatri

Array ( [id] => 9198838 [patent_doc_number] => 20130338153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-19 [patent_title] => '8-(2\'-HETEROCYCYL)PYRIDO[2.3-D]PYRIMIDIN-7(8H)-ONES FOR THE TREATMENT OF CNS DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/702573 [patent_app_country] => US [patent_app_date] => 2011-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 56206 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13702573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10083374 [patent_doc_number] => 09120711 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-01 [patent_title] => 'Carboxylation catalysts' [patent_app_type] => utility [patent_app_number] => 13/702886 [patent_app_country] => US [patent_app_date] => 2011-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7411 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13702886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9827947 [patent_doc_number] => 08937175 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-20 [patent_title] => 'Compounds as ligands for transition metal complexes and materials made thereof, and use therefor' [patent_app_type] => utility [patent_app_number] => 13/704596 [patent_app_country] => US [patent_app_date] => 2011-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1585 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13704596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8720198 [patent_doc_number] => 20130071415 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-21 [patent_title] => 'Heterocyclic Compounds as Janus Kinase Inhibitors' [patent_app_type] => utility [patent_app_number] => 13/699818 [patent_app_country] => US [patent_app_date] => 2011-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21141 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13699818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580875 [patent_doc_number] => 20110294758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'NOVEL ACTIVATORS OF GLUCOKINASE' [patent_app_type] => utility [patent_app_number] => 13/115647 [patent_app_country] => US [patent_app_date] => 2011-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74597 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294758.pdf [firstpage_image] =>[orig_patent_app_number] => 13115647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8211434 [patent_doc_number] => 20120129862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'PROKINETICIN 1 RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/113751 [patent_app_country] => US [patent_app_date] => 2011-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 33571 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20120129862.pdf [firstpage_image] =>[orig_patent_app_number] => 13113751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6017218 [patent_doc_number] => 20110224434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'Prodrugs of Heteroaryl Compounds' [patent_app_type] => utility [patent_app_number] => 13/108956 [patent_app_country] => US [patent_app_date] => 2011-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17475 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20110224434.pdf [firstpage_image] =>[orig_patent_app_number] => 13108956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8697846 [patent_doc_number] => 20130059855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-07 [patent_title] => 'CRYSTAL OF DI(ARYLAMINO)ARYL COMPOUND' [patent_app_type] => utility [patent_app_number] => 13/698183 [patent_app_country] => US [patent_app_date] => 2011-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7960 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13698183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8538390 [patent_doc_number] => 08314111 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-20 [patent_title] => 'Fused bicyclic motor inhibitors' [patent_app_type] => utility [patent_app_number] => 13/106954 [patent_app_country] => US [patent_app_date] => 2011-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59538 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13106954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7561973 [patent_doc_number] => 20110275806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'LOW-ENERGY-CONSUMPTION PROCESS FOR THE PRODUCTION OF HIGH-PURITY MELAMINE, THROUGH THE PYROLYSIS OF UREA, AND RELATIVE EQUIPMENT' [patent_app_type] => utility [patent_app_number] => 13/101702 [patent_app_country] => US [patent_app_date] => 2011-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7843 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275806.pdf [firstpage_image] =>[orig_patent_app_number] => 13101702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5937576 [patent_doc_number] => 20110212966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'ANTIVIRAL AGENTS' [patent_app_type] => utility [patent_app_number] => 13/100931 [patent_app_country] => US [patent_app_date] => 2011-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13861 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212966.pdf [firstpage_image] =>[orig_patent_app_number] => 13100931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9389557 [patent_doc_number] => 08686156 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-01 [patent_title] => 'Thiazole derivatives as pesticides' [patent_app_type] => utility [patent_app_number] => 13/099977 [patent_app_country] => US [patent_app_date] => 2011-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12595 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13099977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7808031 [patent_doc_number] => 20120058985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'CYCLOPROPYL DICARBOXAMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIES' [patent_app_type] => utility [patent_app_number] => 13/098243 [patent_app_country] => US [patent_app_date] => 2011-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20553 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20120058985.pdf [firstpage_image] =>[orig_patent_app_number] => 13098243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10096823 [patent_doc_number] => 09133123 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-15 [patent_title] => 'Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use' [patent_app_type] => utility [patent_app_number] => 13/642227 [patent_app_country] => US [patent_app_date] => 2011-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45225 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13642227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064348 [patent_doc_number] => 20110201619 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'Use of N-Phenyl-2-pyrimidineamine Derivatives Against Mast Cell-based Diseases Like Allergic Disorders' [patent_app_type] => utility [patent_app_number] => 13/090752 [patent_app_country] => US [patent_app_date] => 2011-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7714 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201619.pdf [firstpage_image] =>[orig_patent_app_number] => 13090752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8721461 [patent_doc_number] => 20130072677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-21 [patent_title] => 'NOVEL HYDROXAMIC ACID DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 13/642320 [patent_app_country] => US [patent_app_date] => 2011-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 120156 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13642320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6168394 [patent_doc_number] => 20110196149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'FLUORIDATION METHOD' [patent_app_type] => utility [patent_app_number] => 13/088461 [patent_app_country] => US [patent_app_date] => 2011-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4602 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20110196149.pdf [firstpage_image] =>[orig_patent_app_number] => 13088461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6114360 [patent_doc_number] => 20110190496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'FUSED BICYCLIC mTOR INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/085722 [patent_app_country] => US [patent_app_date] => 2011-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59230 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20110190496.pdf [firstpage_image] =>[orig_patent_app_number] => 13085722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7561961 [patent_doc_number] => 20110275794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => '5-POSITION MODIFIED PYRIMIDINES AND THEIR USE' [patent_app_type] => utility [patent_app_number] => 13/085256 [patent_app_country] => US [patent_app_date] => 2011-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11593 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275794.pdf [firstpage_image] =>[orig_patent_app_number] => 13085256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9621085 [patent_doc_number] => 08791257 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-29 [patent_title] => 'Substituted pyrrolotriazines as protein kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 13/638210 [patent_app_country] => US [patent_app_date] => 2011-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31494 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13638210 [rel_patent_id] =>[rel_patent_doc_number] =>)